The benefits, limitations and opportunities of preclinical models for neonatal drug development

• Asıl Yazarlar: Sarah Campion (Yazar), Amy Inselman (Yazar), Belinda Hayes (Yazar), Costanza Casiraghi (Yazar), David Joseph (Yazar), Fabrizio Facchinetti (Yazar), Fabrizio Salomone (Yazar), Georg Schmitt (Yazar), Julia Hui (Yazar), Karen Davis-Bruno (Yazar), Karen Van Malderen (Yazar), LaRonda Morford (Yazar), Luc De Schaepdrijver (Yazar), Lutz Wiesner (Yazar), Stephanie Kourula (Yazar), Suna Seo (Yazar), Susan Laffan (Yazar), Vijay Urmaliya (Yazar), Connie Chen (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: The Company of Biologists, 2022-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Increased research to improve preclinical models to inform the development of therapeutics for neonatal diseases is an area of great need. This article reviews five common neonatal diseases - bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, perinatal hypoxic-ischemi...